Comparison of the antisecretory and antiucler activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo

Molecular and Cellular Biochemistry

Volumn 236, Issue 1-2, 2002, Pages 83-94

  Bastaki, S M A ^a   Chandranath, S I ^a   Singh, J ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Anaesthetized rat; Dimaprit; EGF; Gastric acid secretion; Gastric ulcer; Pentagastrin; TGF (rat synthetic); TGF fraction 34 43 (rat synthetic); Urogastrone

Indexed keywords

ALCOHOL; AMINO ACID; ANTIULCER AGENT; DIMAPRIT; EPIDERMAL GROWTH FACTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTAGASTRIN; PROSTANOID; STOMACH SECRETION INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; UROGASTRONE; CYCLIC AMP; PROSTAGLANDIN; PROTEIN KINASE C;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; FEMALE; IN VIVO STUDY; MALE; NONHUMAN; RAT; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH ULCER; ANIMAL; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SECRETION; SIGNAL TRANSDUCTION; STOMACH ACID; TIME; WISTAR RAT;

RODENTIA;

ANIMALS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FEMALE; GASTRIC ACID; INDOMETHACIN; MALE; NG-NITROARGININE METHYL ESTER; PROSTAGLANDINS; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0036022142     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016144016908     Document Type: Article

References (69)

1. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening of newborn animals
2. The constitution and properties of two gastrins extracted from hog antral mucosa
3. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type a and b transforming growth factors
4. Transforming growth factors produced by retrovirus transformed rodent fibroblasts and human melanoma cells: Amino acid sequence homology with epidermal growth factor
5. Rat transforming growth factor type I: Structure and relationship to epidermal growth factor
6. Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha
7. Structure function analysis of synthetic and recombinant derivatives of transforming growth factor alpha
8. Transforming growth factor α: An aromatic side chain at position 38 is essential for biological activity
9. Transforming growth factor alpha binds to the epidermal growth factor receptor in gastric mucosa
10. Epidermal growth factor and transforming growth factor alpha bind differently to the epidermal growth factor receptor
11. Transforming growth factor α
12. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism
13. Localization of transforming growth factor and its receptor in gastric mucosa cells. Implications for regulatory role in acid secretion and mucosal renewal
14. Transforming growth factor alpha and epidermal growth factor levels in normal human gastrointestinal mucosa
15. The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action
16. Effect of epidermal growth factor (EGF) and indomethacin on stimulated gastric acid secretion in vitro
17. Ontogenic differences in the inhibition of gastric acid secretion by epidermal growth factor
18. Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor
19. Gastroprotective activity and receptor expression of transforming growth factor alpha, epidermal growth factor and basic fibroblast growth factor in the rat stomach
20. TGFα is a potent mitogen for primary cultures of guinea pig gastric mucous epithelial cells
21. Epidermal growth factor (EGF) inhibits intrinsic factor and acid secretion in histamine-stimulated isolated gastric glands
22. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland
23. Polyunsaturated fatty acids and epidermal growth factor receptor/mitogen-activated protein kinase signaling in mammary cancer
24. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats
25. 2 derivative
26. Transforming growth factor α inhibits secretion of gastric acid
27. + secretion by transforming growth factor alpha: A possible autocrine regulatory mechanism
28. Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat
29. Effect of transforming growth factor (TGFα) on gastric acid secretion in rats and monkeys
30. Inhibition of parietal cell acid secretion is mediated by the classical epidermal growth factor receptor
31. The inhibition of gastric acid secretion by epidermal growth factor
32. Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects
33. Transforming growth factor-alpha and epidermal growth factor expression in human fetal gastrointestinal tract
34. Inhibitory action of urogastrone from pregnant horse's urine on gastric acid secretion
35. Epithelial cell proliferation and uptake of radiolabelled urogastrone in the intestinal tissues following abdominal irradiation in the mouse
36. Epithelial cell proliferation and biodistribution of radiolabelled urogastrone in the gastrointestinal mucosa of young and old mice
37. Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat
38. YM022 ((R)-1-[2,3-dihydro-1-(2′-methylphenacyl)-2-oxo-5-phenyl -1H-1,4-benzodiazepin-3y1]-3-(methylphenyl), urea), a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats
39. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion
40. Autoradiographic identification of a gastrin receptor on the human parietal cell
41. Calcium oscillations in single cultured Chinese hamster ovary cells stably transfected with a cloned human cholecystokinin (CCK B) receptor
42. Structure and function of cyclic nucleotide-dependent protein kinases
43. Roles of G protein subunits in transmembrane signaling
44. Inhibitory action of somatostatin on isolated gastric glands and parietal cells
45. Regulation of gastric acid secretion
46. An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin
47. Electron microscopic evidence for epidermal growth factor receptor (EGF-R)-like immunoreactivity associated with the basolateral surface of gastric parietal cells
48. Epidermal growth factor digested to smaller, less active forms in acidic gastric juice
49. Pancreastatin: A novel peptide inhibitor of parietal cell signal transduction
50. Transforming growth factor-alpha (TGFα) levels in human proximal gastrointestinal epithelium. Effect of mucosal injury and acid inhibition
51. Apical TGFα/EGF receptors mediate enhanced resistance of gastric mucosal cell monolayers to apical acidification
52. Multiple actions of epidermal growth factor and TGFα on gastric parietal cell function
53. Assessment of biological activity of synthetic fragments of transforming growth factor-alpha
54. Substitution of lysine for arginine at position 42 of human transforming growth factor-α eliminates biological activity without changing internal disulfide bonds
55. Transforming growth factor-alpha (TGFα) inhibition of parietal cell secretion: Structural requirements of reactivity
56. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin
57. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat
58. Mechanism of nonsteroidal anti-inflammatory drug-induced gastric damage
59. Mechanism of gastric mucosal cytoprotection by prostaglandins
60. Prostaglandin cytoprotection of gastric mucosa
61. Potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclooxygenase inhibitors
62. A new model of duodenal ulcers induced in rats by indomethacin plus histamine
63. 2 aggravates gastric mucosal injury induced by histamine in rats: Possible role of the increased mucosal vascular permeability
64. Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression
65. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat
66. Mechanism of gastric alkaline response in the stomach after damage. Roles of nitric oxide and prostaglandins
67. Mechanism of acid secretory changes in rat stomach after damage by taurocholate: Role of nitric oxide, histamine and sensory neurons
68. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells
69. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation